Abstract
Heart valves are elegant, dynamic, pliable structures experiencing complex and varied mechanical forces during development and throughout the course of their postnatal lifetime. Recent work has shown a remarkable link between the mechanical environment of these valve leaflets and their structure, function, and biological behavior. Additionally, these mechanobiological responses, while being regulated by a similar set of signaling pathways, may be very different depending on their occurrence during valvulogenesis or during adulthood. This chapter reviews what is currently known about these differentially mechanoregulated signaling pathways in the heart valve, highlighting any gaps in knowledge.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Balachandran K, Sucosky P, Yoganathan AP. Hemodynamics and mechanobiology of aortic valve inflammation and calcification. Int J Inflam. 2011;2011:263870.
Sacks MS, David Merryman W, Schmidt DE. On the biomechanics of heart valve function. J Biomech. 2009;42(12):1804–24.
Sacks MS, Yoganathan AP. Heart valve function: a biomechanical perspective. Philos Trans R Soc Lond B Biol Sci. 2007;362(1484):1369–91.
Merryman WD, et al. Synergistic effects of cyclic tension and transforming growth factor-beta1 on the aortic valve myofibroblast. Cardiovasc Pathol. 2007;16(5):268–76.
Merryman WD, et al. Differences in tissue-remodeling potential of aortic and pulmonary heart valve interstitial cells. Tissue Eng. 2007;13:2281.
Huang HY, Liao J, Sacks MS. In-situ deformation of the aortic valve interstitial cell nucleus under diastolic loading. J Biomech Eng. 2007;129(6):880–9.
Balachandran K, et al. Elevated cyclic stretch induces aortic valve calcification in a bone morphogenic protein-dependent manner. Am J Pathol. 2010;177(1):49–57.
Butcher JT, Nerem RM. Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: effects of steady shear stress. Tissue Eng. 2006;12(4):905–15.
Mahler GJ, Butcher JT. Inflammatory regulation of valvular remodeling: the good(?), the bad, and the ugly. Int J Inflam. 2011;2011:721419.
Atkins SK, et al. Bicuspid aortic valve hemodynamics induces abnormal medial remodeling in the convexity of porcine ascending aortas. Biomech Model Mechanobiol. 2014;13:1209.
Richards JM, et al. The mechanobiology of mitral valve function, degeneration, and repair. J Vet Cardiol. 2012;14(1):47–58.
Balachandran K, et al. Cyclic strain induces dual-mode endothelial-mesenchymal transformation of the cardiac valve. Proc Natl Acad Sci U S A. 2011;108(50):19943–8.
Markwald RR, Butcher JT. The next frontier in cardiovascular developmental biology—an integrated approach to adult disease? Nat Clin Pract Cardiovasc Med. 2007;4(2):60–1.
Wylie-Sears J, et al. Mitral valve endothelial cells with osteogenic differentiation potential. Arterioscler Thromb Vasc Biol. 2011;31(3):598–607.
Goodwin RL, et al. Three-dimensional model system of valvulogenesis. Dev Dyn. 2005;233(1):122–9.
Lindsey SE, Butcher JT, Yalcin HC. Mechanical regulation of cardiac development. Front Physiol. 2014;5:318.
Butcher JT, Simmons CA, Warnock JN. Mechanobiology of the aortic heart valve. J Heart Valve Dis. 2008;17(1):62–73.
Armstrong EJ, Bischoff J. Heart valve development: endothelial cell signaling and differentiation. Circ Res. 2004;95(5):459–70.
Combs MD, Yutzey KE. VEGF and RANKL regulation of NFATc1 in heart valve development. Circ Res. 2009;105(6):565–74.
Combs MD, Yutzey KE. Heart valve development: regulatory networks in development and disease. Circ Res. 2009;105(5):408–21.
Zhou J, et al. Cadherin-11 expression patterns in heart valves associate with key functions during embryonic cushion formation, valve maturation and calcification. Cells Tissues Organs. 2013;198(4):300–10.
Moskowitz IP, et al. Transcription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve development. Proc Natl Acad Sci U S A. 2011;108(10):4006–11.
Hinton RB, Yutzey KE. Heart valve structure and function in development and disease. Annu Rev Physiol. 2011;73:29–46.
Lindsey SE, Butcher JT. The cycle of form and function in cardiac valvulogenesis. Aswan Heart Cent Sci Pract Ser. 2011;2011:10.
Goenezen S, Rennie MY, Rugonyi S. Biomechanics of early cardiac development. Biomech Model Mechanobiol. 2012;11(8):1187–204.
Granados-Riveron JT, Brook JD. The impact of mechanical forces in heart morphogenesis. Circ Cardiovasc Genet. 2012;5(1):132–42.
Boselli F, Freund JB, Vermot J. Blood flow mechanics in cardiovascular development. Cell Mol Life Sci. 2015;72(13):2545–59.
Steed E, Boselli F, Vermot J. Hemodynamics driven cardiac valve morphogenesis. Biochim Biophys Acta. 2016;1863(7B):1760–6.
Johnson B, et al. Altered mechanical state in the embryonic heart results in time-dependent decreases in cardiac function. Biomech Model Mechanobiol. 2015;14(6):1379–89.
Kalogirou S, et al. Intracardiac flow dynamics regulate atrioventricular valve morphogenesis. Cardiovasc Res. 2014;104(1):49–60.
Tao G, Kotick JD, Lincoln J. Heart valve development, maintenance, and disease: the role of endothelial cells. Curr Top Dev Biol. 2012;100:203–32.
Chester AH, et al. The living aortic valve: from molecules to function. Global Cardiol Sci Pract. 2014;2014(1):52–77.
Back M, et al. Biomechanical factors in the biology of aortic wall and aortic valve diseases. Cardiovasc Res. 2013;99(2):232–41.
Riem Vis PW, et al. Environmental regulation of valvulogenesis: implications for tissue engineering. Eur J Cardiothorac Surg. 2011;39(1):8–17.
Camenisch TD, et al. Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat Med. 2002;8(8):850–5.
Miquerol L, Langille BL, Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development. 2000;127(18):3941–6.
Hallaq H, et al. A null mutation of Hhex results in abnormal cardiac development, defective vasculogenesis and elevated Vegfa levels. Development. 2004;131(20):5197–209.
Butcher JT, Markwald RR. Valvulogenesis: the moving target. Philos Trans R Soc Lond B Biol Sci. 2007;362(1484):1489–503.
Johnson EN, et al. NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells. J Biol Chem. 2003;278(3):1686–92.
Rabkin E, et al. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation. 2001;104(21):2525–32.
Chang CP, et al. A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis. Cell. 2004;118(5):649–63.
de la Pompa JL, et al. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature. 1998;392(6672):182–6.
Lambrechts D, Carmeliet P. Sculpting heart valves with NFATc and VEGF. Cell. 2004;118(5):532–4.
Andersson ER, Sandberg R, Lendahl U. Notch signaling: simplicity in design, versatility in function. Development. 2011;138(17):3593–612.
Timmerman LA, et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004;18(1):99–115.
Garg V, et al. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005;437(7056):270–4.
Marvin MJ, et al. Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes Dev. 2001;15(3):316–27.
Hurlstone AF, et al. The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature. 2003;425(6958):633–7.
Liebner S, et al. Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J Cell Biol. 2004;166(3):359–67.
Gitler AD, et al. Molecular markers of cardiac endocardial cushion development. Dev Dyn. 2003;228(4):643–50.
Person AD, et al. Frzb modulates Wnt-9a-mediated beta-catenin signaling during avian atrioventricular cardiac cushion development. Dev Biol. 2005;278(1):35–48.
Ma L, et al. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development. 2005;132(24):5601–11.
Delot EC. Control of endocardial cushion and cardiac valve maturation by BMP signaling pathways. Mol Genet Metab. 2003;80(1–2):27–35.
Liu W, et al. Bmp4 signaling is required for outflow-tract septation and branchial-arch artery remodeling. Proc Natl Acad Sci U S A. 2004;101(13):4489–94.
Kim RY, Robertson EJ, Solloway MJ. Bmp6 and Bmp7 are required for cushion formation and septation in the develo** mouse heart. Dev Biol. 2001;235(2):449–66.
Kaden JJ, et al. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis. J Heart Valve Dis. 2004;13(4):560–6.
Winnier G, et al. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 1995;9(17):2105–16.
Solloway MJ, Robertson EJ. Early embryonic lethality in Bmp5;Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup. Development. 1999;126(8):1753–68.
Inai K, et al. BMP-2 induces cell migration and periostin expression during atrioventricular valvulogenesis. Dev Biol. 2008;315(2):383–96.
Shelton EL, Yutzey KE. Tbx20 regulation of endocardial cushion cell proliferation and extracellular matrix gene expression. Dev Biol. 2007;302(2):376–88.
Shelton EL, Yutzey KE. Twist1 function in endocardial cushion cell proliferation, migration, and differentiation during heart valve development. Dev Biol. 2008;317(1):282–95.
Lincoln J, Alfieri CM, Yutzey KE. BMP and FGF regulatory pathways control cell lineage diversification of heart valve precursor cells. Dev Biol. 2006;292(2):292–302.
Zhao B, et al. BMP and FGF regulatory pathways in semilunar valve precursor cells. Dev Dyn. 2007;236(4):971–80.
Brown CB, et al. Antibodies to the type II TGFbeta receptor block cell activation and migration during atrioventricular cushion transformation in the heart. Dev Biol. 1996;174(2):248–57.
Azhar M, et al. Ligand-specific function of transforming growth factor beta in epithelial-mesenchymal transition in heart development. Dev Dyn. 2009;238(2):431–42.
Person AD, Klewer SE, Runyan RB. Cell biology of cardiac cushion development. Int Rev Cytol. 2005;243:287–335.
Molin DG, et al. Expression patterns of Tgfbeta1-3 associate with myocardialisation of the outflow tract and the development of the epicardium and the fibrous heart skeleton. Dev Dyn. 2003;227(3):431–44.
Beffagna G, et al. Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res. 2005;65(2):366–73.
Hu BC, et al. The association between transforming growth factor beta3 polymorphisms and left ventricular structure in hypertensive subjects. Clin Chim Acta. 2010;411(7–8):558–62.
Conway SJ, Doetschman T, Azhar M. The inter-relationship of periostin, TGF beta, and BMP in heart valve development and valvular heart diseases. ScientificWorldJournal. 2011;11:1509–24.
Chen B, et al. Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat Genet. 2000;24(3):296–9.
Erickson SL, et al. ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. Development. 1997;124(24):4999–5011.
Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–900.
Loffredo CA. Epidemiology of cardiovascular malformations: prevalence and risk factors. Am J Med Genet. 2000;97(4):319–25.
Huang JB, et al. Molecular mechanisms of congenital heart disease. Cardiovasc Pathol. 2010;19(5):e183–93.
Zeng Q, et al. Notch1 promotes the pro-osteogenic response of human aortic valve interstitial cells via modulation of ERK1/2 and nuclear factor-kappaB activation. Arterioscler Thromb Vasc Biol. 2013;33(7):1580–90.
Fukuda D, et al. Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders. Proc Natl Acad Sci U S A. 2012;109(27):E1868–77.
Wang J, Greene SB, Martin JF. BMP signaling in congenital heart disease: new developments and future directions. Birth Defects Res A Clin Mol Teratol. 2011;91(6):441–8.
Yang X, et al. Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1/2. J Thorac Cardiovasc Surg. 2009;138(4):1008–15.
Mohler ER 3rd, et al. Bone formation and inflammation in cardiac valves. Circulation. 2001;103(11):1522–8.
Ankeny RF, et al. Preferential activation of SMAD1/5/8 on the fibrosa endothelium in calcified human aortic valves—association with low BMP antagonists and SMAD6. PLoS One. 2011;6(6):e20969.
ten Dijke P, Arthur HM. Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol. 2007;8(11):857–69.
Pardali E, Goumans MJ, ten Dijke P. Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol. 2010;20(9):556–67.
Doetschman T, et al. Transforming growth factor beta signaling in adult cardiovascular diseases and repair. Cell Tissue Res. 2012;347(1):203–23.
Benke K, et al. The role of transforming growth factor-beta in Marfan syndrome. Cardiol J. 2013;20(3):227–34.
Koch W, et al. Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease. Arterioscler Thromb Vasc Biol. 2006;26(5):1114–9.
Yokota M, et al. Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation. 2000;101(24):2783–7.
Clark-Greuel JN, et al. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events. Ann Thorac Surg. 2007;83(3):946–53.
Walker GA, et al. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res. 2004;95(3):253–60.
Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol. 2007;171(5):1407–18.
Chen JH, et al. Beta-catenin mediates mechanically regulated, transforming growth factor-beta1-induced myofibroblast differentiation of aortic valve interstitial cells. Arterioscler Thromb Vasc Biol. 2011;31(3):590–7.
Hutcheson JD, et al. Serotonin receptors and heart valve disease—it was meant 2B. Pharmacol Ther. 2011;132(2):146–57.
Jian B, et al. Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells. Am J Pathol. 2002;161(6):2111–21.
Xu J, et al. Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells. Am J Pathol. 2002;161(6):2209–18.
Nebigil CG, et al. Ablation of serotonin 5-HT(2B) receptors in mice leads to abnormal cardiac structure and function. Circulation. 2001;103(24):2973–9.
Fabre A, et al. Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice. Eur Respir J. 2008;32(2):426–36.
Vermot J, et al. Reversing blood flows act through klf2a to ensure normal valvulogenesis in the develo** heart. PLoS Biol. 2009;7(11):e1000246.
Gordon WR, et al. Mechanical Allostery: evidence for a force requirement in the proteolytic activation of notch. Dev Cell. 2015;33(6):729–36.
Yanagisawa H, et al. Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development. 1998;125(5):825–36.
Kurihara Y, et al. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J Clin Invest. 1995;96(1):293–300.
Yalcin HC, et al. Hemodynamic patterning of the avian atrioventricular valve. Dev Dyn. 2011;240(1):23–35.
Sun L, Sucosky P. Bone morphogenetic protein-4 and transforming growth factor-beta1 mechanisms in acute valvular response to supra-physiologic hemodynamic stresses. World J Cardiol. 2015;7(6):331–43.
Fisher CI, Chen J, Merryman WD. Calcific nodule morphogenesis by heart valve interstitial cells is strain dependent. Biomech Model Mechanobiol. 2013;12(1):5–17.
Balachandran K, et al. Elevated cyclic stretch and serotonin result in altered aortic valve remodeling via a mechanosensitive 5-HT(2A) receptor-dependent pathway. Cardiovasc Pathol. 2012;21(3):206–13.
Balachandran K, et al. Aortic valve cyclic stretch causes increased remodeling activity and enhanced serotonin receptor responsiveness. Ann Thorac Surg. 2011;92(1):147–53.
Liang YJ, et al. Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-kappaB in cardiomyocytes. Cardiovasc Res. 2006;72(2):303–12.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Tandon, I., Lam, N.T., Balachandran, K. (2018). Mechanical Mediation of Signaling Pathways in Heart Valve Development and Disease. In: Sacks, M., Liao, J. (eds) Advances in Heart Valve Biomechanics. Springer, Cham. https://doi.org/10.1007/978-3-030-01993-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-01993-8_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-01991-4
Online ISBN: 978-3-030-01993-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)